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Junctional Epidermolysis Bullosa (JEB) is an inherited disease which causes skin 
lesions  in  newborn  foals  and  results  in  large  areas  of  skin  loss.  The  mutation 
responsible for the disease is a cytosine insertion in the LAMC2 gene, which results 
in  absent  expression  of  the  laminin  γ2  polypeptide  chain  of  laminin  5.  JEB  is 
inherited  as  an  autosomal  recessive  trait  (Spirito  et  al.  2002,  Milenkovic  et  al. 
2003). Our objective was to analyze Romanian Draft Horses using a set of primers 
which amplify a fragment from the LAMC2 gene possibly containing the insertion 
for correctly identifying the normal homozygous and heterozygous carrier horses for 
the JEB trait. The number of allele peaks depends on whether the horse tested is a 
heterozygote (carrier) or homozygote (normal or JEB affected). Results suggest that 
the genetic test will be useful in identifying horses which are heterozygous for the 
JEB trait and foals with JEB. 
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Introduction 
 
Epidermolysis Bullosa (EB) is a heterogeneous group of mechano-bullous 
disorders characterized by fragility of the skin and the mucous membranes. The 
junctional form of EB, JEB, is characterized by blister formation within the lamina 
lucida of the basement membrane zone and by an autosomal recessive pattern of 
inheritance. In the severe Herlitz variant, H-JEB, tissue cleavage results from the 
mutations in one of the three genes (LAMA3, LAMB3 or LAMC2) (Aumailley et al. 
1998, Pulkkinen et al. 1999). These are encoding the three subunits (a3, b3 and g2) 
of the extracellular adhesion ligand laminin 5 associated with the hemidesmosome-
anchoring  lament  complexes.  Likewise,  cases  of  EB  have  been  described  in 
different species, such as sheep (Bruckner-Tuderman et al. 1991), dogs (Palazzi et 
al. 2000), cats (Olivry et al. 1999), and rats (Brenneman et al. 2000). 
In horses, JEB is an inherited disease that causes skin lesions in newborn 
foals and results in large areas of skin loss. The disease was first discovered in 
Belgian draft horses. Different areas of the body were affected, in particular the   84 
limbs  with  recurrent  loss  of  the  hooves.  The  phenotype  of  the  affected  foals 
suggests a condition in horses similar to H-JEB in humans. Affected foals were 
born with skin blistering, skin and buccal ulceration followed by the loss of the 
hooves, as ascertained by a veterinarian and confirmed by histological examination 
(Milenkovic et al. 2003). The affected skin showed disjunction of the epidermis 
from the underlying dermis at the dermal-epidermal junction. 
In France, a type of lethal junctional EB was described for the first time in 
the Trait Breton and Trait Comtois draft horses and the limited family data are 
compatible with a recessive mode of inheritance (Goureau et al. 1989).  
The mutation associated with the clinical signs of JEB in Belgian and French 
draft horses has been identified and is linked to the γ2 subunit of the laminin-5 
gene. The mutation is a cytosine insertion in the genomic nucleic acid sequence of 
affected horses at position 1368 of the laminin γ2 encoding polynucleotide, a frame 
shift, and a premature termination codon. This results in an absent expression of 
the laminin γ2 polypeptide. An autosomal recessive mode of inheritance of this 
mutation has been verified (Spirito et al. 2002, Milenkovic et al. 2003). 
 
 
Material and Methods 
 
In our research we analyzed a population of Romanian Draft Horses. The 
isolation of genomic DNA from fresh blood was performed with Wizard Genomic 
DNA Extraction Kit (Promega). 
We used one set of primers, which amplify a fragment from the LAMC2 
gene possibly containing the insertion. The forward primer was labeled with 6-
FAM  dye.  PCR  was  performed  in  a  GeneAmp  9700  PCR  System 
(AppliedBiosystems).  The  reactions  were  carried  out  in  25- l  final  volume 
containing PCR Buffer, MgCl2, 200  M of each dNTP, 0.5  M of each primer, 0.5 
units of AmpliTaq Gold DNA Polymerase, diluted DNA (50 ng per reaction) and 
nuclease-free water. PCR amplifications were performed in 0.2 ml tubes using 30 
cycles with denaturation at 95 ºC (30 s), annealing at 57 °C (30 s) and extension at 
72 °C (45 s). The first denaturation step was performed at 95 ºC (10 min) and the 
last extension took 10 min. at 72 °C. 
PCR  products  were  loaded  with  the  GeneScan-500  ROX  Internal  Size 
Standard  (AppliedBiosystems)  into  one  of  the  ABI  PRISM  310  DNA  Genetic 
Analyzer (AppliedBiosystems).  
The  results  were  analyzed  with  the  GeneScan  3.1.2.  Software 
(AppliedBiosystems) which assigns a base pair size for each signal. GeneScan data 
can then be exported directly to Genotyper 2.5.2. Software (AppliedBiosystems) 
for automated genotyping. 
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Results and Discussions 
 
Our objective was to analyze Romanian Draft Horses using a set of primers 
which amplify a fragment from the LAMC2 gene possibly containing the insertion, 
for correctly identifying the normal homozygous and heterozygous carrier horses 
for the JEB trait.  
PCR was performed on DNA samples with fluorescently labeled primers 
designed to amplify the region containing the mutation. The mutation is a single 
base insertion, and thus, carriers have a PCR product that is one base longer than 
the normal allele. The single base difference is detected by analysis of the PCR 
products on an ABI 310 DNA Genetic Analyzer. 
An amplified fragment for a normal horse had 169 bp. The conditions for 
PCR were selected so that the two primers could amplify the DNA from normal, 
carrier and JEB affected horses.  
In our experiment successful amplification yields one or two allele peaks 
with an expected size of 169 and (or) 170 bp. The number of allele peaks depends 
on whether the individual tested is a heterozygote (carrier) or homozygote (normal 
or JEB affected). If we test a normal horse we must obtain just one peak at 169 bp. 
If we analyze a homozygous affected horse we also obtain just one peak, but at 170 
bp. If the horse is a heterozygous carrier we must obtain two peaks at 169 and 170 
bp because one allele is normal and the other one contains the insertion.  
We did not find any carrier or affected horses among the Romanian Draft 
Horse population analyzed. 
In  Figure  1  the  profile  for  a heterozygous  carrier and  for  a  homozygous 
normal horse are shown.  
 
 
Figure 1: Genotyper software analysis of PCR amplification product for a heterozygous carrier 
and for a normal homozygous horse. 
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Conclusions 
 
The identification of the causal mutation of JEB is of great importance to 
draft horse breeders. A rapid, simple genotyping method by DNA amplification 
from  blood  or  hair  samples  detecting  normal  and  mutated  fragments  is  now 
available for genetic tests. The identification of healthy carriers for the mutation 
allows the development of different breeding strategies. Population reproductions 
can be conducted, avoiding  mating between carriers to obtain unaffected foals. 
Alternatively,  breeder  associations  may  decide  to  eradicate  the  mutation  by 
preventing all carriers to reproduce. 
In conclusion, this study proposes a rapid molecular test for the identification 
of healthy carriers which will help the breeders to eliminate the disorder from their 
populations. 
Consequently, the investigation of possible occurrences of the affected gene 
among other draft horse populations from other countries and among other breeds 
will be of interest. 
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